Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837315 · ClinicalTrials.gov registry record · NA
Improving Brief Marijuana Interventions With a Behavioral Economic Supplement
A NA study of Marijuana Use, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
- 1
- Study location
NCT02837315: Completed NA study of Marijuana Use, sponsored by University of Memphis.
NCT02837315 is a NA study of Marijuana Use that has completed, run by University of Memphis. The registered enrollment target is 133 participants, roughly in line with the 123-participant average among 3 other Marijuana Use trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02837315, a NA study of Marijuana Use, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of a Substance-Free Activity Session (SFAS) as a supplement to a brief motivation intervention (BMI) in reducing marijuana use and drug-related consequences in college student
Primary Outcome
Electronic timeline follow-back to measure marijuana use days
Conditions Studied
Interventions
- BEHAVIORAL Brief Motivational Intervention (BMI)
- BEHAVIORAL Substance-Free Activity Session (SFAS)
- BEHAVIORAL Relaxation Session
Study Locations (1)
Tennessee
- University of Memphis - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2014-10-23 |
| Est. Completion | 2016-11-30 |
| Phase | NA |
What the finished NCT02837315 record still lists
NCT02837315 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 123-participant average among 3 other Marijuana Use trials with a reported enrollment target.
The record links to 1 condition, with Marijuana Use appearing as the primary indexed condition, and to 3 interventions - of which Brief Motivational Intervention (BMI) is the first listed.
NCT02837315 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02837315 about?
NCT02837315 is a clinical study titled "Improving Brief Marijuana Interventions With a Behavioral Economic Supplement". The purpose of this study is to evaluate the efficacy of a Substance-Free Activity Session (SFAS) as a supplement to a brief motivation intervention (BMI) in reducing marijuana use and drug-related consequences in college student
What is the current status of trial NCT02837315?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2014-10-23. Estimated completion is 2016-11-30.
What conditions does trial NCT02837315 study?
This clinical trial studies the following conditions: Marijuana Use.
What interventions are being tested in trial NCT02837315?
The interventions under investigation include: Brief Motivational Intervention (BMI) (BEHAVIORAL), Substance-Free Activity Session (SFAS) (BEHAVIORAL), Relaxation Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT02837315?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02837315 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marijuana Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI